Description of articles included in the cost review
| Study | Location | Results |
| Begnel et al24 | Kenya | Over half (61%) of participants were willing to pay for PrEP and 78% reported that the maximum amount they were willing to pay for a 1 month supply was <US$5. |
| Havens et al21 | USA: Omaha, Nebraska | Among participants who completed follow-up visits at the community pharmacy, half (6 of 12) stated they would be willing to pay at least US$20 quarterly for continued PrEP visits and half (6 of 12) were willing to pay up to US$60 quarterly. |
| Tung et al19 20 | USA: Seattle, Washington state | In the 2017 abstract, 96% of patients (235/245) paid US$0 for their PrEP. Initial startup costs were recouped after 9 months of operations. In the 2018 article, 98% of patients paid US$0 for their PrEP (total n=695). Financial sustainability of the model was dependent on the ability of pharmacists to bill insurance plans for their services in accordance with local legislative changes requiring commercial insurances to recognise pharmacists as providers. |
PrEP, pre-exposure prophylaxis.